Stock listing

NASDAQ:POZN POZEN Inc Stock

Follow POZEN Inc into a list and get an email when it puts out news.

Last close · NASDAQ:POZN

$5.95 USD

Close on Feb 8, 2016 · No longer trades

Oct 11, 2000 to last close -52.3% · monthly closes, Oct 11, 2000 – Feb 8, 2016
Lowest – highest close
$2.26 – $21.75 USDSince Oct 11, 2000 · lowest Oct 3, 2011 · highest Dec 22, 2000

Delisted NASDAQ:POZN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:POZN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

POZEN Inc on 6ix

Decks
5 decks · latest Nov 9, 2015

Decks

DeckKindSlidesDate
Q3 2015 Earnings PresentationEarnings18 slidesNov 9, 2015
Merger or Acquisition (September 2015)Merger or acquisition11 slidesSep 28, 2015
Merger or Acquisition (August 2015)Merger or acquisition27 slidesAug 10, 2015
Merger or Acquisition (July 2015)Merger or acquisition26 slidesJul 20, 2015
BIO CEO & Investor Conference 2013Conference30 slidesFeb 12, 2013

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adrian Adams
Other companies: Akebia Therapeutics, Inc. (Chairperson · Since at least Dec 12, 2018); Talphera, Inc. (Director · Since at least Feb 11, 2013); Impel Neuropharma Inc (COB, CEO and President, Director · Apr 22, 2021 – Jan 26, 2022 · Past); Aralez Pharmaceuticals Inc (Chief Executive Officer, Director · Feb 5, 2016 – May 11, 2017 · Past); Auxilium Pharmaceuticals Inc (CEO and President, Director · Dec 7, 2011 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (President and CEO, Director · Feb 22, 2010 – May 13, 2011 · Past); Amylin Pharmaceuticals LLC (Director · Oct 29, 2007 – Aug 8, 2012 · Past); Sepracor Inc (President & CEO, Director · Mar 1, 2007 – Oct 20, 2009 · Past); Neurocrine Biosciences, Inc. (Director · Jun 30, 2006 – Jun 30, 2006 · Past); Kos Pharmaceuticals Inc (President & CEO, Director · Jan 26, 2006 – Dec 13, 2006 · Past)
Chief Executive Officer, Director · May 31, 2015 – Nov 11, 2015 · Past
Andrew Koven
Other companies: MetaVia Inc. (Chairman of the Board · Since at least Jul 9, 2021); Kala Bio, Inc. (Director · Since at least Sep 28, 2017); Aralez Pharmaceuticals Inc (President & Chief Business Off · Feb 5, 2016 – Jun 4, 2018 · Past); Auxilium Pharmaceuticals Inc (EVP, CAO, GC and Secretary · Feb 3, 2012 – Jan 29, 2015 · Past); Inspire Pharmaceuticals Inc (EVP & Chief Admin & Legal Ofc · May 10, 2010 – May 13, 2011 · Past); Sepracor Inc (Exec VP, General Counsel · Mar 1, 2007 – Oct 20, 2009 · Past); Kos Pharmaceuticals Inc (EVP, General Counsel · Jan 26, 2006 – Dec 13, 2006 · Past)
President, Chief Business Ofc. · May 31, 2015 – Jun 3, 2015 · Past
Mark A. Glickman
Other companies: BioStem Technologies, Inc. (Director · Since at least Aug 6, 2026); MetaVia Inc. (Independent Director · Since at least May 11, 2023); TherapeuticsMD, Inc. (Co-Chief Executive Officer · Oct 15, 2021 – Dec 6, 2022 · Past); Esperion Therapeutics, Inc. (Chief Commercial Officer · Dec 20, 2018 – Jan 2, 2020 · Past); Aralez Pharmaceuticals Inc (Chief Commercial Officer · Feb 5, 2016 – Mar 19, 2018 · Past); Auxilium Pharmaceuticals Inc (EVP - Sales and Marketing · Feb 3, 2012 – Jan 29, 2015 · Past)
Chief Commercial Officer · Jun 22, 2015 – Jun 22, 2015 · Past
James P. Tursi
Other companies: MetaVia Inc. (Independent Director · Since at least Nov 1, 2023); Endo International PLC (Executive VP, Global R&D · Feb 24, 2022 – Jul 15, 2022 · Past); Antares Pharma Inc (EVP, Chief Medical Officer · Aug 6, 2018 – Jun 13, 2019 · Past); Aralez Pharmaceuticals Inc (Chief Medical Officer · Feb 5, 2016 – May 14, 2018 · Past); Auxilium Pharmaceuticals Inc (Chief Medical Officer · Feb 14, 2012 – Jan 29, 2015 · Past)
Chief Medical Officer · Oct 1, 2015 – Oct 1, 2015 · Past
Seth Rudnick
Other companies: G1 Therapeutics Inc (Director · May 16, 2017 – Jun 29, 2021 · Past); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 11, 2017 · Past); Square 1 Financial Inc (Director · Mar 24, 2014 – Oct 6, 2015 · Past); Immunicon Corp (Director · Jan 19, 2006 – Jan 19, 2006 · Past)
Director · Jul 25, 2011 – Jun 23, 2015 · Past
Elizabeth Cermak
Other companies: Moleculin Biotech, Inc. (Director · Since at least Oct 2, 2020); Clarus Therapeutics Holdings Inc (Director · Sep 9, 2021 – Jun 7, 2022 · Past); SteadyMed Ltd (Director · Jun 10, 2015 – Aug 30, 2018 · Past)
EVP, Chief Commercial Officer · Sep 14, 2009 – Mar 15, 2013 · Past
Neal Fowler
Other companies: Emergent BioSolutions Inc. (Independent Director · Since at least Oct 1, 2023); Liquidia Corporation (Chief Executive Officer, Director · Nov 19, 2020 – Nov 19, 2020 · Past); Aralez Pharmaceuticals Inc (Director · Feb 5, 2016 – May 11, 2017 · Past)
Director · Jun 10, 2010 – Jul 28, 2015 · Past
Eric Trachtenberg
Other companies: Kala Bio, Inc. (SEE REMARKS · Apr 2, 2018 – Jan 4, 2024 · Past); Aralez Pharmaceuticals Inc (GC, CCO & Secretary · Feb 5, 2016 – Mar 19, 2018 · Past)
Deputy General Counsel · Jun 22, 2015 – Jun 22, 2015 · Past
Ted G Wood
Other companies: King Pharmaceuticals Inc (Director · Apr 28, 2006 – Feb 28, 2011 · Past); Alpha Natural Resources Inc (Director · Jan 25, 2006 – May 17, 2012 · Past)
Director · Jan 3, 2006 – Jan 3, 2006 · Past
John E Barnhardt
Other companies: Aralez Pharmaceuticals Inc (VP, Finance and Administration · Feb 4, 2016 – Feb 5, 2016 · Past)
VP, Finance and Administration · Jan 3, 2006 – Dec 31, 2015 · Past
All 29 people
PersonSeat
Scott J Charles
Other companies: Aralez Pharmaceuticals Inc (Chief Financial Officer · Feb 5, 2016 – Jul 28, 2017 · Past)
Vice President of Finance · Jul 27, 2015 – Jul 27, 2015 · Past
William L Hodges
Other companies: Novan Inc (Interim Chief Financial Office · Mar 24, 2017 – Sep 15, 2017 · Past)
Chief Financial Officer · Jul 27, 2015 – Dec 31, 2015 · Past
W James Alexander
Other companies: BioCryst Pharmaceuticals, Inc. (SR. VP, Chief Medical Officer · Jun 19, 2006 – Jul 31, 2007 · Past)
Senior VP, Product Development · Jan 3, 2006 – Jan 3, 2006 · Past
Angela Maria LarsonDirector · Jun 3, 2009 – Jun 9, 2011 · Past
Bruce A TomasonDirector · Jan 3, 2006 – May 6, 2008 · Past
Dennis L McNamaraSVP & Chief Business Officer · Jan 1, 2014 – Dec 31, 2015 · Past
Donald H NammDirector · Mar 14, 2006 – Mar 14, 2006 · Past
Everardus OrlemansSr. VP, Product Development · Mar 25, 2009 – Mar 15, 2010 · Past
Gilda Marie ThomasSr, VP, Gen Cnsl & Secretary · Feb 20, 2008 – Dec 31, 2015 · Past
James Joseph MauzeyDirector · Mar 14, 2006 – Jun 9, 2011 · Past
James R ButlerDirector · Jan 3, 2006 – Jan 3, 2006 · Past
John G FortChief Medical Officer · Dec 10, 2009 – Dec 31, 2015 · Past
John R PlachetkaPresident, CEO and Chairman, Director · Jan 3, 2006 – Dec 31, 2014 · Past
Kristina M AdomonisSenior VP, Business Dev · Jan 3, 2006 – Jan 3, 2007 · Past
Marshall E ReeseExec VP, Prod Dev · Jan 3, 2006 – May 6, 2008 · Past
Martin NicklassonDirector · Jun 9, 2011 – Jun 6, 2013 · Past
Paul J RizzoDirector · Jun 3, 2009 – Jun 3, 2009 · Past
Peter J WiseDirector · Jan 3, 2006 – May 16, 2008 · Past
Tomas S BocanegraEVP, Development · Jul 5, 2011 – Mar 15, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about POZEN Inc.